PORTAGE BIOTECH INC. Quarterly General And Administrative Expense in USD from Q2 2020 to Q1 2024

Taxonomy & unit
ifrs-full: USD
Summary
Portage Biotech Inc. quarterly/annual General And Administrative Expense history and growth rate from Q2 2020 to Q1 2024.
  • Portage Biotech Inc. General And Administrative Expense for the quarter ending March 31, 2024 was $1.35M, a 2.25% decline year-over-year.
  • Portage Biotech Inc. General And Administrative Expense for the twelve months ending March 31, 2024 was $5.66M, a 28.3% decline year-over-year.
  • Portage Biotech Inc. annual General And Administrative Expense for 2023 was $5.66M, a 28.3% decline from 2022.
  • Portage Biotech Inc. annual General And Administrative Expense for 2022 was $7.9M, a 10.4% decline from 2021.
  • Portage Biotech Inc. annual General And Administrative Expense for 2021 was $8.82M, a 72% increase from 2020.
General And Administrative Expense, Trailing 12 Months (USD)
General And Administrative Expense, Quarterly (USD)
General And Administrative Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $5.66M $1.35M -$31K -2.25% Jan 1, 2024 Mar 31, 2024 20-F 2024-08-14
Q4 2023 $5.7M $1.25M -$970K -43.6% Oct 1, 2023 Dec 31, 2023 6-K 2024-02-28
Q3 2023 $6.67M $1.69M -$395K -18.9% Jul 1, 2023 Sep 30, 2023 6-K 2023-11-28
Q2 2023 $7.06M $1.37M -$841K -38% Apr 1, 2023 Jun 30, 2023 6-K 2023-08-29
Q1 2023 $7.9M $1.38M -$1.15M -45.6% Jan 1, 2023 Mar 31, 2023 20-F 2024-08-14
Q4 2022 $9.05M $2.22M -$17K -0.76% Oct 1, 2022 Dec 31, 2022 6-K 2024-02-28
Q3 2022 $9.07M $2.09M +$88K +4.4% Jul 1, 2022 Sep 30, 2022 6-K 2023-11-28
Q2 2022 $8.98M $2.21M +$164K +8.01% Apr 1, 2022 Jun 30, 2022 6-K 2023-08-29
Q1 2022 $8.82M $2.53M -$1.25M -33% Jan 1, 2022 Mar 31, 2022 20-F 2024-08-14
Q4 2021 $10.1M $2.24M +$1.79M +396% Oct 1, 2021 Dec 31, 2021 6-K 2023-03-01
Q3 2021 $8.28M $2M +$1.62M +432% Jul 1, 2021 Sep 30, 2021 6-K 2022-11-29
Q2 2021 $6.65M $2.05M +$1.53M +293% Apr 1, 2021 Jun 30, 2021 6-K 2022-08-29
Q1 2021 $5.13M $3.78M Jan 1, 2021 Mar 31, 2021 20-F 2023-07-31
Q4 2020 $452K Oct 1, 2020 Dec 31, 2020 6-K 2022-02-25
Q3 2020 $376K Jul 1, 2020 Sep 30, 2020 6-K 2021-11-23
Q2 2020 $521K Apr 1, 2020 Jun 30, 2020 6-K 2021-08-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.